Browsing by Author "Silva, Durcilene Alves da"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- Acetylated cashew gum and fucan for incorporation of lycopene rich extract from red guava (Psidium guajava L.) in nanostructured systems: antioxidant and antitumor capacityPublication . Andrades, Eryka Oliveira de; Costa, João Marcos Antônio Rodrigues da; Neto, Francisco Edmar Moreira de Lima; Araujo, Alyne Rodrigues de; Ribeiro, Fabio de Oliveira Silva; Vasconcelos, Andreanne Gomes; Oliveira, Antônia Carla de Jesus; Sobrinho, José Lamartine Soares; Almeida, Miguel Peixoto de; Carvalho, Ana P.; Dias, Jhones Nascimento; Silva, Ingrid Gracielle Martins; Albuquerque, Patrícia; Pereira, Ildinete Silva; Rabello, Doralina do Amaral; Amorim, Adriany das Graças Nascimento; Leite, José Roberto de Souza de Almeida; Silva, Durcilene Alves daIndustrial application of lycopene is limited due to its chemical instability and low bioavailability. This study proposes the development of fucan-coated acetylated cashew gum nanoparticles (NFGa) and acetylated cashew gum nanoparticles (NGa) for incorporation of the lycopene-rich extract from red guava (LEG). Size, polydispersity, zeta potential, nanoparticles concentration, encapsulation efficiency, transmission electron microscopy (TEM) and atomic force microscopy (AFM) were used to characterize nanoparticles. The antioxidant activity was determinated and cell viability was evaluated in the human breast cancer cells (MCF-7) and human keratinocytes (HaCaT) by MTT assay. The toxic effect was evaluated by hemolysis test and by Galleria mellonella model. NFGa showed higher stability than NGa, having a size of 162.10 ± 3.21 nm, polydispersity of 0.348 ± 0.019, zeta potential -30.70 ± 0.53 mV, concentration of 6.4 × 109 nanoparticles/mL and 60% LEG encapsulation. Microscopic analysis revealed a spherical and smooth shape of NFGa. NFGa showed antioxidant capacity by ABTS method and ORAC assay. The NFGa presented significant cytotoxicity against MCF-7 from the lowest concentration tested (6.25-200 μg/mL) and did not affect the cell viability of the HaCaT. NFGa showed non-toxic effect in the in vitro and in vivo models. Therefore, NFGa may have a promising application in LEG stabilization for antioxidant and antitumor purposes.
- Chitosan-based silver nanoparticles: a study of the antibacterial, antileishmanial and cytotoxic effectsPublication . Lima, Douglas dos Santos; Gullon, Beatriz; Cardelle-Cobas, Alejandra; Brito, Lucas M.; Rodrigues, Klinger A. F.; Quelemes, Patrick V.; Ramos-Jesus, Joilson; Arcanjo, Daniel D. R.; Plácido, Alexandra; Batziou, Krystallenia; Quaresma, Pedro; Eaton, Peter; Delerue-Matos, Cristina; Carvalho, Fernando Aecio; Silva, Durcilene Alves da; Pintado, M. E.; Leite, José Roberto de SáSilver nanoparticles have been studied as an alternative for treatment of microbial infections and leishmaniasis, without promoting induction of microbial or parasite resistance. In this study, chitosan-based silver nanoparticles were synthesized from silver nitrate (AgNO3), sodium borohydride as a reducing agent, and the biopolymer chitosan as a capping agent. The chitosan-based silver nanoparticles were characterized by ultraviolet-visible, Fourier transform infrared, dynamic light scattering, zeta potential, atomic force microscopy, and transmission electron microscope. The antibacterial assay was performed by determination of the minimum inhibitory concentration. The antileishmanial and the cytotoxic effects induced by AgNO3, chitosan, and chitosan-based silver nanoparticles were analyzed by resazurin and MTT colorimetric assays, respectively. AgNO3, chitosan, and chitosan-based silver nanoparticles induced a marked activity against all bacterial strains and promastigote forms of Leishmania amazonensis at minimum inhibitory concentrations ranging from 1.69 to 3.38 μg Ag/mL. Interestingly, the chitosan-based silver nanoparticles presented less cytotoxicity than the AgNO3 alone and were more active against L. amazonensis than solely chitosan. Furthermore, the cytotoxic concentrations (CC50) of both chitosan and chitosan-based silver nanoparticles against macrophages were significantly higher than the IC50 against promastigotes. Thus, the chitosan-based silver nanoparticles represent a promising alternative for the treatment of microbial infections and leishmaniasis.